Drug research

Chemotherapy

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Onivyde / Leucovorin (LV) / Fluorouracil (5-FU)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ CancerNCT04082364	MacroGenics	Phase 2, Phase 3	Completed	2024-01-15Actual
Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer PatientsNCT02826486	BLRX	Phase 2	Completed	2022-09-06Actual

MacroGenicsCompletedPrimary completion: 2024-01-15 · Actual

Trial details

BLRXCompletedPrimary completion: 2022-09-06 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.